Article citationsMore>>

Selvin, E., Rawlings, A.M., Grams, M., Klein, R., Sharrett, A.R., Steffes, M., et al. (2014) Fructosamine and Glycated Albumin for Risk Stratification and Prediction of Incident Diabetes and Microvascular Complications: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities (ARIC) Study. The Lancet Diabetes & Endocrinology, 2, 279-288.
https://doi.org/10.1016/S2213-8587(13)70199-2

has been cited by the following article:

• TITLE: Association of GA/HbA1c Ratio with Diabetic Retinopathy

  AUTHORS: Tianyao Zhang, Xu Zheng

  KEYWORDS: Type 2 Diabetes, Diabetic Retinopathy, GA/HbA1c Ratio

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.14 No.8, August 10, 2023

  ABSTRACT: Objectives: The aim of this study was to explore the potential correlation between the GA/HbA1c ratio and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), as the GA/HbA1c ratio serves as a marker for glycemic variability. Methods: A total of 2565 T2D patients were included in this study and grouped into five categories based on the diagnostic criteria for DR. We examined the impact of the GA/HbA1c ratio on the progression of diabetes. Results: The non-DR group exhibited lower GA/HbA1c levels compared to the DR group. Additionally, as the severity of DR increased among the five groups, there was a corresponding increase in the GA/HbA1c ratio. Logistic regression analysis demonstrated that the GA/HbA1c ratio independently elevated the risk of DR occurrence. Conclusions: The GA/HbA1c ratio can independently predict the occurrence and progression of diabetic retinopathy.